[go: up one dir, main page]

MX2010006830A - A palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent. - Google Patents

A palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent.

Info

Publication number
MX2010006830A
MX2010006830A MX2010006830A MX2010006830A MX2010006830A MX 2010006830 A MX2010006830 A MX 2010006830A MX 2010006830 A MX2010006830 A MX 2010006830A MX 2010006830 A MX2010006830 A MX 2010006830A MX 2010006830 A MX2010006830 A MX 2010006830A
Authority
MX
Mexico
Prior art keywords
gum
nucleotide
nucleoside
nutritional composition
taste
Prior art date
Application number
MX2010006830A
Other languages
Spanish (es)
Inventor
Patrick Joseph Gerardus Hendrikus Kamphuis
Martine Groenendijk
Esther Jacqueline De Kort
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40094223&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2010006830(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of MX2010006830A publication Critical patent/MX2010006830A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
    • A23L29/262—Cellulose; Derivatives thereof, e.g. ethers
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
    • A23L29/269—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of microbial origin, e.g. xanthan or dextran
    • A23L29/272—Gellan
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/13—Nucleic acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Dispersion Chemistry (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pediatric Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Seasonings (AREA)

Abstract

The present invention relates to the use of a taste masking agent selected from the group of cellulose; starch; xanthan gum; gellan gum; alginate; galactomannans such as fenugreek, guar gum, tara gum, locust bean gum, and cassia gum; gum karaya; gum tragacanth; carrageenan; and mixture thereof, for improving one or more of mouth feel, taste, aftertaste and smell of a liquid aqueous nutritional composition comprising a nucleotide and/or a nucleoside. It also relates to a nutritional composition comprising an unsavoury nucleotide and/or a nucleoside component, having improved sensory characteristics such as improved mouth feel, taste, aftertaste and smell.In particular, it relates to a composition comprising said un- savoury nucleotide and/or a nucleoside component, in particular comprising an uridine- containing nucleotide and/or a nucleoside in combination with an unsavoury edible oil, such as a fish oil.
MX2010006830A 2007-12-20 2008-12-22 A palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent. MX2010006830A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07123811 2007-12-20
PCT/NL2008/050124 WO2009082203A1 (en) 2007-12-20 2008-03-04 Liquid nucleotides/nucleosides-containing product
PCT/NL2008/050843 WO2009082227A1 (en) 2007-12-20 2008-12-22 A palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent

Publications (1)

Publication Number Publication Date
MX2010006830A true MX2010006830A (en) 2010-09-30

Family

ID=40094223

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2010006829A MX2010006829A (en) 2007-12-20 2008-03-04 Liquid nucleotides/nucleosides-containing product.
MX2010006830A MX2010006830A (en) 2007-12-20 2008-12-22 A palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2010006829A MX2010006829A (en) 2007-12-20 2008-03-04 Liquid nucleotides/nucleosides-containing product.

Country Status (12)

Country Link
US (5) US8282965B2 (en)
EP (3) EP2222311B1 (en)
CN (2) CN101951923B (en)
BR (2) BRPI0822111B8 (en)
DK (1) DK2244591T3 (en)
ES (3) ES2411726T3 (en)
HU (1) HUE035468T2 (en)
MX (2) MX2010006829A (en)
PL (3) PL2222311T3 (en)
PT (1) PT2244591T (en)
RU (2) RU2446807C2 (en)
WO (2) WO2009082203A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009002148A1 (en) * 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
RU2529815C2 (en) 2007-06-26 2014-09-27 Н.В. Нютрисиа Improvement of memory in patients with 24-26 points by mental state mini-examination
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
PL2222311T3 (en) 2007-12-20 2013-08-30 Nutricia Nv Liquid nucleotides/nucleosides-containing product
US8916540B2 (en) * 2008-01-15 2014-12-23 Academia Sinica Antibiotic compositions and related screening methods
EP2248270B1 (en) * 2008-02-01 2015-03-11 BlackBerry Limited System and method for uplink timing synchronization in conjunction with discontinuous reception
EP2616046B1 (en) 2010-09-13 2016-08-31 Bev-RX, Inc. Aqueous drug delivery system comprising off-flavor masking agent
WO2012044242A1 (en) 2010-09-29 2012-04-05 Procordia Food Ab Use of a food product comprising viscous fibres which has a beneficial effect on cognitive performance.
WO2012091542A1 (en) 2010-12-28 2012-07-05 N.V. Nutricia Combination of components for the prevention and treatment of frailty
WO2013012313A1 (en) * 2011-07-18 2013-01-24 N.V. Nutricia Use of a nucleotide for improving the heat stability of an aqueous micellar casein composition
AU2012331692B2 (en) * 2011-10-31 2017-03-02 N.V. Nutricia Composition for improving neuropsychological test battery score
WO2013066153A1 (en) * 2011-10-31 2013-05-10 N.V. Nutricia Composition for improving neuropsychological test battery score
WO2013066151A1 (en) 2011-10-31 2013-05-10 N.V. Nutricia Improving recognition
WO2013066152A1 (en) * 2011-10-31 2013-05-10 N.V. Nutricia Method for improving executive function
RU2667968C2 (en) * 2012-03-02 2018-09-25 Н.В. Нютрисиа Method for improving functional synaptic connectivity
US20140271998A1 (en) * 2013-03-15 2014-09-18 Aryeh HECHT Fortified egg white products
EP3071055B1 (en) * 2013-11-19 2020-01-01 Omniblend Innovation Pty Ltd Composition and method for control of post-prandial glucose
WO2015115885A1 (en) * 2014-01-31 2015-08-06 N.V. Nutricia Method for reducing white matter lesions, white matter hyperintensities (wmh), leukoaraiosis or periventricular white matter disease in elderly
WO2015157937A1 (en) * 2014-04-16 2015-10-22 华为技术有限公司 Software upgrade method and terminal
WO2017069613A1 (en) 2015-10-23 2017-04-27 N.V. Nutricia Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients
WO2017155387A1 (en) * 2016-03-08 2017-09-14 N.V. Nutricia Method for supporting memory function and/or cognitive function
CN115120607A (en) * 2022-06-07 2022-09-30 珍奥集团股份有限公司 Application of nucleotide mixture in preparation for preventing and treating Alzheimer's disease

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3600197A (en) 1968-08-27 1971-08-17 Merck & Co Inc Flavor enhancing compositions for foods and beverages
EP0175468A3 (en) 1984-08-10 1987-07-22 Sentrachem Limited Eicosanoids for use in cancer therapy
JP2525624B2 (en) 1987-09-21 1996-08-21 雪印乳業株式会社 Baby milk powder containing polyunsaturated fatty acids
SU1658975A1 (en) * 1988-10-25 1991-06-30 Дальневосточный Технологический Институт Рыбной Промышленности И Хозяйства Method for enhancing taste of food products
GB9009861D0 (en) * 1990-05-02 1990-06-27 Glaxo Group Ltd Chemical compounds
JPH0517372A (en) 1991-07-10 1993-01-26 Yoshitomi Pharmaceut Ind Ltd Crude drug combination composition with reduced unpleasant taste
JPH06237734A (en) 1991-11-06 1994-08-30 Sanwa Kagaku Kenkyusho Co Ltd Food composition for hypofunctional disease
JPH0717855A (en) 1992-09-02 1995-01-20 Maruha Corp Brain function improving composition, learning ability enhancer, memory enhancing agent, dementia preventive agent, dementia therapeutic agent, or functional food having a brain function improving effect
US5378488A (en) 1993-06-10 1995-01-03 Abbott Laboratories Aseptic processing of infant formula
US5563177A (en) 1995-01-30 1996-10-08 American Home Products Corporation Taste masking guaifenesin containing liquids
JP3576318B2 (en) 1996-06-19 2004-10-13 明治乳業株式会社 Nutrient composition containing nucleic acid-related substance
JPH10136937A (en) 1996-11-08 1998-05-26 Takashi Morita Nutritive composite food for improving brain cell function, potentiating vascular cell and improving systemic cell function
DK0843972T3 (en) 1996-11-20 2002-12-02 Nutricia Nv Food composition containing fats for the treatment of metabolic disorders
ES2273409T3 (en) 1997-03-28 2007-05-01 Eisai Co., Ltd. ORAL MEDICINES THAT PREVENT UNFORGETTABLE AND SIMILAR FLAVOR.
EP0891719A1 (en) 1997-07-14 1999-01-20 N.V. Nutricia Nutritional composition containing methionine
JP3731983B2 (en) 1997-08-27 2006-01-05 明治製菓株式会社 Drugs for improving night noise in dementia dogs
US20050203053A1 (en) * 1999-07-30 2005-09-15 Wurtman Richard J. Uridine administration improves phosphatide synthesis, synaptic transmission and cogntive function
US20070004670A1 (en) 1998-07-31 2007-01-04 Richard Wurtman Compositions containing citicoline, and methods of use thereof
US8518882B2 (en) 1998-07-31 2013-08-27 Massachusetts Institute Of Technology Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
US6472378B2 (en) * 1998-08-31 2002-10-29 Pro-Neuron, Inc. Compositions and methods for treatment of mitochondrial diseases
FR2787799B1 (en) 1998-12-23 2001-03-09 Rhodia Chimie Sa COMPOSITION COMPRISING AN INORGANIC BARK AND A CORE COMPRISING AT LEAST ONE POLYHYDROXYL COMPOUND
KR20000046974A (en) * 1998-12-31 2000-07-25 윤재승 Composition for oral administration comprising aceglutamide aluminum and carageenan
EP1090636A1 (en) 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. High lipid diet
GB9925709D0 (en) 1999-10-30 1999-12-29 Smithkline Beecham Plc Composition
US20020187180A1 (en) 2000-03-02 2002-12-12 Calton Gary J Modifying undesirable tastes
US6835750B1 (en) 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
EP2319508A1 (en) 2000-05-01 2011-05-11 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
PL209031B1 (en) 2001-04-30 2011-07-29 Trommsdorff Arzneimittel Pharmaceutically active uridine esters
US6942874B2 (en) * 2001-05-25 2005-09-13 Linguagen Corp. Nucleotide compounds that block the bitter taste of oral compositions
EP1285590A1 (en) 2001-08-08 2003-02-26 Société des Produits Nestlé S.A. Lipid blends
NL1019368C2 (en) 2001-11-14 2003-05-20 Nutricia Nv Preparation for improving receptor performance.
US20030114415A1 (en) 2001-12-14 2003-06-19 Wurtman Richard J. Compositions and methods for treating and preventing memory impairment using citicoline
US20040001817A1 (en) 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
ES2309901T3 (en) 2003-10-24 2008-12-16 N.V. Nutricia IMMUNOMODULATING OLIGOSACARIDS.
US7090879B2 (en) 2004-03-18 2006-08-15 Abbott Laboratories Nutritional formula containing select carotenoid combinations
BRPI0510857A (en) * 2004-05-13 2007-12-26 Massachusetts Inst Technology effects of uridine on dopamine release
WO2006031683A2 (en) 2004-09-15 2006-03-23 Massachusetts Institute Of Technology Compositions containing uridine, and methods utilizing same
EP1656839A1 (en) 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
US20060252775A1 (en) 2005-05-03 2006-11-09 Henderson Samuel T Methods for reducing levels of disease associated proteins
CA2645647C (en) 2005-05-23 2016-07-12 Massachusetts Institute Of Technology Compositions containing pufa and/or uridine and methods of use thereof
EP1915144A4 (en) 2005-06-20 2009-08-19 Accera Inc Method to reduce oxidative damage and improve mitochondrial efficiency
JP5967855B2 (en) 2005-06-30 2016-08-10 サントリーホールディングス株式会社 Composition having an activity of reducing daytime activity and / or depressive symptoms
JP5697293B2 (en) 2005-06-30 2015-04-08 サントリーホールディングス株式会社 Composition having an improving effect on lowering of higher brain function due to organic brain injury
AU2006269405B2 (en) 2005-07-08 2013-01-17 Dsm Ip Assets B.V. Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions
WO2007058523A1 (en) 2005-11-17 2007-05-24 N.V. Nutricia Composition with docosapentaenoic acid
US20070140992A1 (en) 2005-12-21 2007-06-21 Lynn Schick Taste masking of essential oils using a hydrocolloid
EP1800675B1 (en) * 2005-12-23 2011-05-18 N.V. Nutricia Composition comprising polyunsaturated fatty acids, proteins, manganese and/or molybden and nucleosides/nucleotides for treating dementia
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
WO2009002148A1 (en) 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
RU2529815C2 (en) 2007-06-26 2014-09-27 Н.В. Нютрисиа Improvement of memory in patients with 24-26 points by mental state mini-examination
PL2222311T3 (en) 2007-12-20 2013-08-30 Nutricia Nv Liquid nucleotides/nucleosides-containing product
JP5397321B2 (en) 2009-06-09 2014-01-22 株式会社デンソー Parking assistance system

Also Published As

Publication number Publication date
CN101951923B (en) 2013-10-30
CN101951790A (en) 2011-01-19
CN101951923A (en) 2011-01-19
US8604000B2 (en) 2013-12-10
RU2446807C2 (en) 2012-04-10
MX2010006829A (en) 2010-09-30
ES2645864T3 (en) 2017-12-11
EP2244591A1 (en) 2010-11-03
WO2009082227A1 (en) 2009-07-02
EP2244591B1 (en) 2017-08-16
EP2222311B1 (en) 2013-03-27
US20160058869A1 (en) 2016-03-03
EP2609812B1 (en) 2018-08-29
PT2244591T (en) 2017-09-22
US20130012469A1 (en) 2013-01-10
US20110105594A1 (en) 2011-05-05
PL2222311T3 (en) 2013-08-30
EP2222311A1 (en) 2010-09-01
US8282965B2 (en) 2012-10-09
US9132196B2 (en) 2015-09-15
DK2244591T3 (en) 2017-10-23
US9687555B2 (en) 2017-06-27
RU2010130160A (en) 2012-01-27
WO2009082203A1 (en) 2009-07-02
US20140162973A1 (en) 2014-06-12
BRPI0822111A2 (en) 2015-06-16
PL2244591T3 (en) 2018-01-31
ES2697149T3 (en) 2019-01-22
BRPI0822111B8 (en) 2021-05-25
RU2010130161A (en) 2012-01-27
BRPI0822111B1 (en) 2021-03-09
HUE035468T2 (en) 2018-05-02
BRPI0821636A2 (en) 2014-12-23
CN101951790B (en) 2017-03-29
PL2609812T3 (en) 2019-02-28
US20110027391A1 (en) 2011-02-03
ES2411726T3 (en) 2013-07-08
RU2484670C2 (en) 2013-06-20
EP2609812A1 (en) 2013-07-03

Similar Documents

Publication Publication Date Title
MX2010006830A (en) A palatable nutritional composition comprising a nucleotide and/or a nucleoside and a taste masking agent.
ATE434389T1 (en) THICKENER COMPOSITION FOR DYSPHAGIA PATIENTS
TW200738817A (en) Blends of biopolymers with acrylic copolymers
PT1876906E (en) Nutritional supplement or functional food comprising oil combination
MX2009005765A (en) Low swelling starch.
RU2010151986A (en) COVERING FRAGRANCE MATERIAL FOR A CIGARETTE, METHOD FOR PRODUCING IT AND A CIGARETTE
MXPA04003593A (en) Starch.
EA200970754A1 (en) FOOD PRODUCT, CONTAINING ALGINATE
EP2060187A4 (en) Edible oil or fat, process for producing the same, and chocolate containing oil or fat composition
WO2007126727A3 (en) WATER SOLUBLE β-GLUCAN, GLUCOSAMINE, AND N-ACETYLGLUCOSAMINE COMPOSITIONS AND METHODS FOR MAKING THE SAME
IN2012DN03632A (en)
MX2010008910A (en) Use of alternan as a thickening agent and thickening agent compositions containing alternan and another thickening agent.
MX340198B (en) Optimized flavored polymeric compositions.
PT2155188E (en) Methods and compositions for treating recurrent cancer
HUE049048T2 (en) Protein concentrate from starch containing grains: composition, method of making, and uses thereof
WO2007014075A3 (en) Rnai modulation of the rho-a gene in research models
MX360480B (en) Pseudo-loaf food compositions.
MX2009005101A (en) Ketomethionine ketals and their derivatives.
MX2012012616A (en) Methods and compositions for inducing satiety.
WO2007033066A3 (en) Sweetener and aroma compositions
MX349111B (en) A particulate flavor delivery system, a method of making it and use thereof.
EP2090302A4 (en) Dietary supplement, anti-fatigue agent or physical endurance enhancer, functional food, or cosmetic
UA106744C2 (en) Aerated emulsion and the method its production
EG24404A (en) Beverages and foodstuffs resistant to light induced flavour changes, processes for making the same and compositions for imparting such resistance
ATE465210T1 (en) WATER-DISPPERSIBLE COMPOSITION CONTAINING XANTHANE

Legal Events

Date Code Title Description
FA Abandonment or withdrawal